[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX14287A - Procedimiento para preparar acidos oxoftalazinil-aceticos heterociclicos - Google Patents

Procedimiento para preparar acidos oxoftalazinil-aceticos heterociclicos

Info

Publication number
MX14287A
MX14287A MX1428788A MX1428788A MX14287A MX 14287 A MX14287 A MX 14287A MX 1428788 A MX1428788 A MX 1428788A MX 1428788 A MX1428788 A MX 1428788A MX 14287 A MX14287 A MX 14287A
Authority
MX
Mexico
Prior art keywords
oxoftalazinyl
hetero
prepare
procedure
cyclic acids
Prior art date
Application number
MX1428788A
Other languages
English (en)
Inventor
Eric Robert Larson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX14287A publication Critical patent/MX14287A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX1428788A 1987-12-21 1988-12-21 Procedimiento para preparar acidos oxoftalazinil-aceticos heterociclicos MX14287A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13617987A 1987-12-21 1987-12-21

Publications (1)

Publication Number Publication Date
MX14287A true MX14287A (es) 1993-06-01

Family

ID=22471693

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1428788A MX14287A (es) 1987-12-21 1988-12-21 Procedimiento para preparar acidos oxoftalazinil-aceticos heterociclicos

Country Status (16)

Country Link
EP (1) EP0322153A3 (es)
JP (1) JPH0692402B2 (es)
KR (1) KR910000438B1 (es)
CN (1) CN1035116A (es)
AU (1) AU609559B2 (es)
CA (1) CA1299181C (es)
DK (1) DK712388A (es)
FI (1) FI885886A (es)
HU (1) HU207086B (es)
IL (1) IL88729A (es)
MX (1) MX14287A (es)
MY (1) MY103505A (es)
NZ (1) NZ227441A (es)
PT (1) PT89268B (es)
YU (1) YU46578B (es)
ZA (1) ZA889519B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels
FR2682108B1 (fr) * 1991-10-07 1994-01-07 Lipha Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
US6878522B2 (en) * 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
CN101058558B (zh) * 2007-05-28 2013-04-10 沈阳药科大学 具有醛糖还原酶抑制活性的4-氧代-1(4h)-喹啉羧酸类化合物、组合物及其制备方法
FR2926556B1 (fr) * 2008-01-22 2010-02-19 Sanofi Aventis Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748280A (en) * 1985-11-07 1988-05-31 Pfizer Inc. Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)
DE3684410D1 (de) * 1985-11-07 1992-04-23 Pfizer Heterocyclische oxophthalazinylessigsaeure.
CA1299178C (en) * 1985-11-07 1992-04-21 Banavara Lakshmana Mylari Heterocyclic oxophtalazinyl acetic acids
ES2031813T3 (es) * 1985-11-11 1993-01-01 Asta Pharma Ag Procedimiento para la preparacion de derivados de 4-bencil-1-(2h)-ftalazinona.
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
JPS6419077A (en) * 1987-07-13 1989-01-23 Yamanouchi Pharma Co Ltd Thiazolidine derivative

Also Published As

Publication number Publication date
DK712388A (da) 1989-07-31
HU207086B (en) 1993-03-01
ZA889519B (en) 1990-08-29
JPH01211585A (ja) 1989-08-24
YU230788A (en) 1990-10-31
HUT56552A (en) 1991-09-30
AU2733788A (en) 1989-06-22
CN1035116A (zh) 1989-08-30
MY103505A (en) 1993-06-30
EP0322153A2 (en) 1989-06-28
KR890009888A (ko) 1989-08-04
AU609559B2 (en) 1991-05-02
IL88729A0 (en) 1989-07-31
YU46578B (sh) 1993-11-16
KR910000438B1 (ko) 1991-01-25
PT89268B (pt) 1993-07-30
FI885886A (fi) 1989-06-22
FI885886A0 (fi) 1988-12-20
IL88729A (en) 1996-07-23
EP0322153A3 (en) 1990-08-16
JPH0692402B2 (ja) 1994-11-16
DK712388D0 (da) 1988-12-21
PT89268A (pt) 1989-12-29
CA1299181C (en) 1992-04-21
NZ227441A (en) 1990-12-21

Similar Documents

Publication Publication Date Title
ES529594A0 (es) Procedimiento para preparar nuevos acidos 3-amino-1-benzazepin-2-ona-1-alcanoicos
ES550692A0 (es) Procedimiento para preparar nuevas somatostatinas
ES557240A0 (es) Procedimiento para preparar nuevos 2-arilimidazoles
BR8804312A (pt) Aparelho para amortecer o deslocamento de elementos componentes
ES557644A0 (es) Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos
ES551439A0 (es) Procedimiento para preparar 4h-1-benzopiran-4-onas
BR8901146A (pt) Pa para helice carenada
ES543630A0 (es) Acidos 1-ciclopropilquinolon-3-carboxilicos
ES550241A0 (es) Procedimiento para preparar nuevos derivados imidazo
ES541689A0 (es) Procedimiento para preparar alfa-aminoacidos sustituidos
MX159506A (es) Procedimiento para preparar acidos quinolincarboxilicos
ES552935A0 (es) Procedimiento para la produccion de d-l-amino acidos
ES550240A0 (es) Procedimiento para preparar nuevos derivados imidazo
ES551940A0 (es) Procedimiento para preparar esteres de alquilamidobetainas
MX173764B (es) Ureasa acida y procedimiento para producirla
MX14287A (es) Procedimiento para preparar acidos oxoftalazinil-aceticos heterociclicos
ES543524A0 (es) Procedimiento para preparar benzoxazolil- y benzotiazolil- aminoacidos
ES549804A0 (es) Procedimiento para preparar nuevos derivados imidazo
ES2016229A4 (es) Proceso para producir n-fosfonometilglicina
ES548236A0 (es) Procedimiento para preparar adenosinas n6 sustituidas
ES554092A0 (es) Procedimiento para la obtencion de viniciclopropancarboxilatos
ES548235A0 (es) Procedimiento para preparar n6-benzopirano- y benzotiopira- no-adenosinas
ES557313A0 (es) Procedimiento para preparar derivados de fenilpirazina
ES545512A0 (es) Procedimiento para la preparacion de acidos arilalcanoicos
ES553632A0 (es) Procedimiento para preparar esteres de acidos 6-bromopiridin-2-il-fosforicos